• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology Inc (NQ: NAUT )

    2.490 -0.170 (-6.39%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Nautilus Biotechnology Inc

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
    Via Benzinga
    Recap: Nautilus Biotechnology Q3 Earnings
    Nautilus Biotechnology (NASDAQ:NAUT) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:05 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Recap: Nautilus Biotechnology Q2 Earnings
    Nautilus Biotechnology (NASDAQ:NAUT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Top 5 Health Care Stocks That May Crash This Month
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Reports First Quarter 2023 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Announces “First Access Challenge” Winners
    Researchers from Buck Institute for Research on Aging, Brigham Young University and University of Southern California awarded early access to Nautilus’ single-molecule protein analysis platform 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Earnings Scheduled For February 23, 2023
    Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
    Via Benzinga
    Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Expands to San Diego
    Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
    Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus’ next-generation proteome analysis platform to advance the study of a rare childhood cancer 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 49 companies hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday's trading, 138 companies set new 52-week lows. 
    Via Benzinga
    Nautilus Biotechnology Launches “First Access Challenge”
    Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis... 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Reports Third Quarter 2022 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    $7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
    The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
      
    Via Benzinga
    Earnings Scheduled For November 1, 2022
    Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion. 
    Via Benzinga
    Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
    Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. 
    Via Benzinga
    $1.2 Million Bet On Gannett? Check Out These 3 Penny Stocks Insiders Are Buying
    U.S. stock futures traded slightly higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
    Via Benzinga
    Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    A Preview Of Nautilus Biotechnology's Earnings
    Nautilus Biotechnology (NASDAQ:NAUT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! 
    Via InvestorPlace
    Earnings Scheduled For August 2, 2022
    Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.